Close Menu

USPTO

Title: RNA Interference Modulators of Hedgehog Signaling and Uses Thereof
Patent Number: 8,802,639
Filed: March 24, 2005

Title: Sustained-release Nucleic Acid Matrix Compositions
Patent Number: 8,795,726
Filed: Jan. 18, 2011

Title: RNA Sequence-specific Mediators of RNA Interference
Patent Number: 8,790,922
Filed: Oct. 4, 2010

Title: Oligoribonucleotides and Methods of Use Thereof for Treatment of Alopecia, Acute Renal Failure, and Other Diseases
Patent Number: 8,765,699

Title: Methods for Normalizing and for Identifying Small Nucleic Acids
Patent Number: 8,741,569
Filed: Oct. 23, 2009

Title: Compositions and Methods for Treatment of Prostate and Other Cancer
Patent Number: 8,722,872
Filed: June 23, 2009

Title: Methods for Eliminating or Reducing the Expression of a Gene in a Filamentous Fungal Strain
Patent Number: 8,716,023

Title: System for Targeted Delivery of Therapeutic Agents
Patent Number: 8,709,483
Filed: Sept. 26, 2008

NEW YORK (GenomeWeb) – Following the release of the US Patent and Trademark Office's guidelines on how its examiners should interpret the US Supreme Court's decision in Association for Molecular Pathology et al. v.

Title: MADS Gene Regulatory Sequences for Expressing Gene Products in Plant Reproductive Tissue
Patent Number: 8,679,844

Pages

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.